Stryker Total Assets 2006-2019 | SYK

Stryker total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Stryker total assets for the quarter ending March 31, 2019 were $25.937B, a 17.19% increase year-over-year.
  • Stryker total assets for 2018 were $27.229B, a 22.67% increase from 2017.
  • Stryker total assets for 2017 were $22.197B, a 8.62% increase from 2016.
  • Stryker total assets for 2016 were $20.435B, a 25.96% increase from 2015.
Stryker Annual Total Assets
(Millions of US $)
2018 $27,229
2017 $22,197
2016 $20,435
2015 $16,223
2014 $17,279
2013 $15,743
2012 $13,206
2011 $12,146
2010 $10,895
2009 $9,071
2008 $7,603
2007 $7,354
2006 $5,874
2005 $4,993
Stryker Quarterly Total Assets
(Millions of US $)
Q1 2019 $25,937
Q4 2018 $27,229
Q3 2018 $22,084
Q2 2018 $21,570
Q1 2018 $22,133
Q4 2017 $22,197
Q3 2017 $21,485
Q2 2017 $21,292
Q1 2017 $20,517
Q4 2016 $20,435
Q3 2016 $20,187
Q2 2016 $20,520
Q1 2016 $19,668
Q4 2015 $16,223
Q3 2015 $15,917
Q2 2015 $16,819
Q1 2015 $16,580
Q4 2014 $17,279
Q3 2014 $17,515
Q2 2014 $17,229
Q1 2014 $16,159
Q4 2013 $15,743
Q3 2013 $14,883
Q2 2013 $14,382
Q1 2013 $14,089
Q4 2012 $13,206
Q3 2012 $12,777
Q2 2012 $12,262
Q1 2012 $12,459
Q4 2011 $12,146
Q3 2011 $12,083
Q2 2011 $11,596
Q1 2011 $11,231
Q4 2010 $10,895
Q3 2010 $10,772
Q2 2010 $10,060
Q1 2010 $10,098
Q4 2009 $9,071
Q3 2009 $8,459
Q2 2009 $7,924
Q1 2009 $7,585
Q4 2008 $7,603
Q3 2008 $7,575
Q2 2008 $8,025
Q1 2008 $7,754
Q4 2007 $7,354
Q3 2007 $6,859
Q2 2007 $6,420
Q1 2007 $6,077
Q4 2006 $5,874
Q3 2006 $5,399
Q2 2006 $5,109
Q1 2006 $4,994
Q4 2005 $4,993
Q3 2005 $4,397
Q2 2005 $4,168
Q1 2005 $4,068
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $68.704B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.025B 26.02
Medtronic (MDT) Ireland $117.659B 17.20
Boston Scientific (BSX) United States $51.899B 24.88
Baxter (BAX) United States $38.763B 24.43
Zimmer Biomet Holdings (ZBH) United States $23.843B 15.32
Smith & Nephew SNATS (SNN) United Kingdom $18.247B 0.00
ResMed (RMD) United States $16.172B 30.90
Canopy Growth (CGC) Canada $15.352B 0.00
Bio-Rad Laboratories (BIO) United States $8.842B 46.88
Aurora Cannabis (ACB) Canada $8.802B 86.80
Perrigo (PRGO) Ireland $6.755B 11.42
Hill-Rom Holdings (HRC) United States $6.504B 19.72
Insulet (PODD) United States $6.200B 451.74
GW Pharmaceuticals (GWPH) United Kingdom $5.280B 0.00
Haemonetics (HAE) United States $5.104B 41.87
ICU Medical (ICUI) United States $4.630B 27.62
Hutchison China MediTech (HCM) China $3.565B 0.00
NuVasive (NUVA) United States $3.164B 25.84
Neogen (NEOG) United States $3.071B 49.94
Agios Pharmaceuticals (AGIO) United States $2.941B 0.00
Quidel (QDEL) United States $2.233B 23.17
National Vision Holdings (EYE) United States $2.120B 45.18
Aphria (APHA) $1.712B 0.00
HEXO (HEXO) $1.455B 0.00
Cardiovascular Systems (CSII) United States $1.377B 790.80
Phibro Animal Health (PAHC) United States $1.168B 17.50
AtriCure (ATRC) United States $1.136B 0.00
VAREX IMAGING (VREX) United States $1.083B 22.98
Lantheus Holdings (LNTH) United States $0.941B 25.00
NanoString Technologies (NSTG) United States $0.941B 0.00
Omeros (OMER) United States $0.914B 0.00
MacroGenics (MGNX) United States $0.913B 0.00
PetIQ (PETQ) United States $0.806B 19.58
Cerus (CERS) United States $0.754B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.753B 21.11
TG Therapeutics (TGTX) United States $0.609B 0.00
LeMaitre Vascular (LMAT) United States $0.541B 26.20
OraSure Technologies (OSUR) United States $0.529B 24.37
Surmodics (SRDX) United States $0.527B 76.59
Quanterix (QTRX) United States $0.498B 0.00
Meridian Bioscience (VIVO) United States $0.462B 14.13
Evolus (EOLS) United States $0.440B 0.00
BioLife Solutions (BLFS) United States $0.343B 107.18
Utah Medical Products (UTMD) United States $0.311B 21.52
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.310B 0.00
Vapotherm (VAPO) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.267B 0.00
Zynex (ZYXI) United States $0.240B 24.80
Owens & Minor (OMI) United States $0.226B 4.79
Cytosorbents (CTSO) United States $0.223B 0.00
Bovie Medical (APYX) United States $0.204B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Chembio Diagnostics (CEMI) United States $0.134B 0.00
Fonar (FONR) United States $0.134B 7.05
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.103B 0.00
InfuSystems Holdings (INFU) United States $0.099B 0.00
United-Guardian (UG) United States $0.094B 20.70
Neurotrope (NTRP) United States $0.091B 0.00
Insys Therapeutics (INSY) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 20.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.042B 0.00
GUARDION HEALTH (GHSI) United States $0.032B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.029B 0.00
BRAINSWAY LTD (BWAY) Israel $0.027B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Myomo (MYO) United States $0.016B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 4.60